4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-072151
Chief Business Officer sold 1,823 shares at $31.34 ($57,133)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McNeill Jonathan Chief Business Officer | 2024-06-11 | Sale | −1,823 | $31.34 | $57,133 | 134,811 | D |
| Open-market sales · 1,823 sh · avg $31.34 · $57,133 | |||||||
Loading xslF345X05/ownership.xml…